Effect of Tuina along “bladder meridian” alleviating intervertebral disc degeneration by regulating the transforming growth factor-β1/Smad signaling pathway in a rabbit model

  • Chengguo SU ,
  • Xiaoyan ZHAO ,
  • Jiangnan YE ,
  • Xin ZHANG ,
  • Yuqing JIANG ,
  • Junjie GUO ,
  • Xiyuan ZHANG ,
  • Wenchuan QI ,
  • Jun ZHU
Expand
  • 1 Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
    2 Clinical Medical School, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China

Received date: 2022-03-23

  Accepted date: 2022-07-15

  Online published: 2023-08-28

Supported by

National Natural Science Foundation of China: Based on TGF-β1/Smads Signaling Pathway to Study the Effect Mechanism of Tuina along the Bladder Meridian on Intervertebral Disc Degeneration(82004497);China Postdoctoral Science Foundation: Based on TGF-β1/RhoA/JNK Signaling Pathway to Study the Effect Mechanism of Tuina along the Bladder Meridian on Intervertebral Disc Degeneration(2021M693788)

Abstract

OBJECTIVE: The aim of this study was to investigate the protective effects of Tuina (a traditional Chinese massage therapy) on intervertebral disc (IVD) degeneration and the regulatory mechanisms of the transforming growth factor-β1 (TGF-β1)/small mothers against decapentaplegic (Smad) signaling pathway.
METHODS: Thirty New Zealand white rabbits were randomized into five groups: the control group, model group, model + Tuina group (Tuina group), model + TGF-β1 group (TGF-β1 group), and model + TGF-β1 inhibitor SB431542 group (SB431542 group). The model was established by posterolateral annulus fibrosus puncturing (AFP). Recombinant TGF-β1 and inhibitor SB431542 was injected into the TGF-β1 group and SB431542 group with a microsyringe, respectively. The rabbits in the Tuina group received Tuina treatment along the bladder meridian for 4 weeks. Magnetic resonance imaging (MRI) was performed on rabbits before AFP and after 4 weeks of intervention. Lumbar IVDs (L2-L3 to L4-L5) were harvested after intervention. Histopathological changes in the IVDs were measured by hematoxylin and eosin (HE) staining. Type I collagen was analyzed by immunohistochemistry detection. The expression level of matrix metalloproteinase-3 (MMP3) was determined by enzyme-linked immunosorbent assay. Cell apoptosis was evaluated by terminal deoxynucleotidyl transferase-mediated nick end labeling and Western blotting. Real-time polymerase chain reaction and Western blotting were used to analyze the expression of TGF-β1 and Smad2/3/4 and a disintegrin and metalloproteinase with thrombospondin motifs 5.
RESULTS: Posterolateral AFP induced IVD degeneration in rabbits with histopathological damage and noticeable changes in MRI images. Tuina alleviated histo-pathological changes and reversed the expression of extracellular matrix degeneration-related molecules and apoptosis-related proteins. Furthermore, AFP induced the activation of TGF-β1 and Smad2/3/4, whereas Tuina therapy markedly reduced the protein expression of Smad2/3 and the gene expression of TGF-β1 and Smad2/3/4. Additionally, the TGF-β1/Smad signaling pathway was activated in the TGF-β1 group, while the TGF-β1/Smad signaling pathway was inhibited in the SB431542 group.
CONCLUSION: Posterolateral AFP induced disc degeneration as determined by MRI assessment and histological analysis. Tuina alleviated disc degeneration, possibly by inhibiting the fibrotic response mediated by the TGF-β1/Smad pathway, thus alleviating extracellular matrix degeneration and reducing cell apoptosis.

Cite this article

Chengguo SU , Xiaoyan ZHAO , Jiangnan YE , Xin ZHANG , Yuqing JIANG , Junjie GUO , Xiyuan ZHANG , Wenchuan QI , Jun ZHU . Effect of Tuina along “bladder meridian” alleviating intervertebral disc degeneration by regulating the transforming growth factor-β1/Smad signaling pathway in a rabbit model[J]. Journal of Traditional Chinese Medicine, 2023 , 43(5) : 991 -1000 . DOI: 10.19852/j.cnki.jtcm.2023.05.005

References

1. Ma K, Chen S, Li Z, et al. Mechanisms of endogenous repair failure during intervertebral disc degeneration. Osteoarthritis Cartilage 2019; 27: 41-8.
2. Vo NV, Hartman RA, Yurube T, Jacobs LJ, Sowa GA, Kang JD. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. Spine J 2013; 13: 331-41.
3. Liu H, Kang H, Song C, et al. Urolithin a inhibits the catabolic effect of tnfα on nucleus pulposus cell and alleviates intervertebral disc degeneration in vivo. Front Pharmacol 2018; 9: 1043.
4. Molinos M, Almeida CR, Caldeira J, Cunha C, Gon?alves RM, Barbosa MA. Inflammation in intervertebral disc degeneration and regeneration. J R Soc Interface 2015; 12: 20150429.
5. Henry N, Clouet J, Le Bideau J, Le Visage C, Guicheux J. Innovative strategies for intervertebral disc regenerative medicine: From cell therapies to multiscale delivery systems. Biotechnol Adv 2018; 36: 281-94.
6. Fontana G, See E, Pandit A. Current trends in biologics delivery to restore intervertebral disc anabolism. Adv Drug Deliv Rev 2015; 84: 146-58.
7. Juch J, Maas ET, Ostelo R, et al. Effect of radiofrequency denervation on pain intensity among patients with chronic low back pain: the mint randomized clinical trials. JAMA 2017; 318: 68-81.
8. Frapin L, Clouet J, Delplace V, Fusellier M, Guicheux J, Le Visage C. Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors. Adv Drug Deliv Rev 2019; 149-50: 49-71.
9. Chen X, Zhu L, Wu G, Liang Z, Yang L, Du Z. A comparison between nucleus pulposus-derived stem cell transplantation and nucleus pulposus cell transplantation for the treatment of intervertebral disc degeneration in a rabbit model. Int J Surg 2016; 28: 77-82.
10. Lund T, Oxland TR. Adjacent level disk disease-is it really a fusion disease? Orthop Clin North Am 2011; 42: 529-41.
11. Mo Z, Li D, Zhang R, Chang M, Yang B, Tang S. Comparisons of the effectiveness and safety of Tuina, acupuncture, traction, and chinese herbs for lumbar disc herniation: a systematic review and network Meta-analysis. Evid Based Complement Alternat Med 2019; 2019: 6821310.
12. Furlan AD, Giraldo M, Baskwill A, Irvin E, Imamura M. Massage for low-back pain. Cochrane Database Syst Rev 2015; 2015: D1929.
13. Miao Z, Tong Z, Ye J, et al. Tuina for lumbar disc herniation: a protocol for systematic review and Meta-analysis. Medicine (Baltimore) 2021; 100: e24203.
14. Huang LS, Huang PP, Tong XB, Li ZL, Fang YP, Liao J. Effects of chiropractics on intervertebral disk extracell matrix and metabolic enzymes in rats with cervical spondylosis. Zhen Ci Yan Jiu 2017; 42: 321-6.
15. Shu J, Li D, Tao W, Chen S. Observation on the curative effect of massage manipulation combined with core strength training in patients with chronic nonspecific low back pain. Evid Based Complement Alternat Med 2021; 2021: 7534577.
16. Won ES, Lee H, Kang JH. Effectiveness and safety assessment of orthopedic device (LSM-01) for low back pain: a randomized, single-blinded, sham-controlled, parallel-group, pilot clinical trial. Medicine (Baltimore) 2022; 101: e28527.
17. Tan H, Tumilty S, Chapple C, Liu L, Othman R, Baxter GD. Acupoints sensitization in people with and without chronic low back pain: a matched-sample cross-sectional study. J Back Musculoskelet Rehabil 2023; 36: 137-46.
18. Goo B, Kim JH, Kim EJ, et al. Thread embedding acupuncture for herniated intervertebral disc of the lumbar spine: a multicenter, randomized, patient-assessor-blinded, controlled, parallel, clinical trial. Complement Ther Clin Pract 2022; 46: 101538.
19. Ding F, Shao ZW, Xiong LM. Cell death in intervertebral disc degeneration. Apoptosis 2013; 18: 777-85.
20. Feng G, Zha Z, Huang Y, et al. Sustained and bioresponsive two-stage delivery of therapeutic mirna via polyplex micelle-loaded injectable hydrogels for inhibition of intervertebral disc fibrosis. Adv Healthc Mater 2018; 7: e1800623.
21. Chen S, Liu S, Ma K, Zhao L, Lin H, Shao Z. TGF-β signaling in intervertebral disc health and disease. Osteoarthritis Cartilage Online 2019; 27: 1109-17.
22. Jin H, Shen J, Wang B, Wang M, Shu B, Chen D. TGF-β signaling plays an essential role in the growth and maintenance of intervertebral disc tissue. FEBS Lett 2011; 585: 1209-15.
23. Zieba J, Forlenza KN, Khatra JS, et al. TGFβ and BMP dependent cell fate changes due to loss of filamin b produces disc degeneration and progressive vertebral fusions. PLoS Genet 2016; 12: e1005936.
24. Tian Y, Yuan W, Li J, et al. TGFβ regulates Galectin-3 expression through canonical Smad3 signaling pathway in nucleus pulposus cells: implications in intervertebral disc degeneration. Matrix Biol 2016; 50: 39-52.
25. Kim KK, Sheppard D, Chapman HA. TGF-β1 signaling and tissue fibrosis. Cold Spring Harb Perspect Biol 2018; 10: a022293.
26. Xu Y, Qu X, Zhou J, et al. Pilose antler peptide-3.2KD ameliorates adriamycin-induced myocardial injury through TGF-β/SMAD signaling pathway. Front Cardiovasc Med 2021; 8: 659643.
27. Bian Q, Ma L, Jain A, et al. Mechanosignaling activation of TGFβ maintains intervertebral disc homeostasis. Bone Res 2017; 5: 17008.
28. Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol 2016; 12: 325-38.
29. Masuda K, Aota Y, Muehleman C, et al. A novel rabbit model of mild, reproducible disc degeneration by an anulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine (Phila Pa 1976) 2005; 30: 5-14.
30. Yang H, Cao C, Wu C, et al. TGF-βl suppresses inflammation in cell therapy for intervertebral disc degeneration. Sci Rep 2015; 5: 13254.
31. Wang WJ, Yu XH, Wang C, et al. MMPs and ADAMTSs in intervertebral disc degeneration. Clin Chim Acta 2015; 448: 238-46.
32. Livshits G, Popham M, Malkin I, et al. Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine Study. Ann Rheum Dis 2011; 70: 1740-5.
33. Takatalo J, Karppinen J, Niinim?ki J, et al. Does lumbar disc degeneration on magnetic resonance imaging associate with low back symptom severity in young Finnish adults? Spine (Phila Pa 1976) 2011; 36: 2180-9.
34. Feng C, Yang M, Lan M, et al. ROS: Crucial intermediators in the pathogenesis of intervertebral disc degeneration. Oxid Med Cell Longev 2017; 2017: 5601593.
35. Yao C, Guo G, Huang R, et al. Manual therapy regulates oxidative stress in aging rat lumbar intervertebral discs through the SIRT1/FOXO1 pathway. Aging (Albany NY) 2022; 14: 2400-17.
36. Sudhir G, Jayabalan V, Sellayee S, Gadde S, Kailash K. Is there an interdependence between paraspinal muscle mass and lumbar disc degeneration? A MRI based study at 2520 levels in 504 patients. J Clin Orthop Trauma 2021; 22: 101576.
37. Kader DF, Wardlaw D, Smith FW. Correlation between the MRI changes in the lumbar multifidus muscles and leg pain. Clin Radiol 2000; 55: 145-9.
38. Zhu F, Duan W, Zhong C, Ji B, Liu X. The protective effects of dezocine on interleukin-1β-induced inflammation, oxidative stress and apoptosis of human nucleus pulposus cells and the possible mechanisms. Bioengineered 2022; 13: 1399-410.
39. Freemont AJ. The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxford) 2009; 48: 5-10.
40. Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ, Hoyland JA. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans 2007; 35: 652-5.
41. Antoniou J, Goudsouzian NM, Heathfield TF, et al. The human lumbar endplate. Evidence of changes in biosynthesis and denaturation of the extracellular matrix with growth, maturation, aging, and degeneration. Spine (Phila Pa 1976) 1996; 21: 1153-61.
42. Kong M, Zhang Y, Song M, et al. Myocardin-related transcription factor a nuclear translocation contributes to mechanical overload-induced nucleus pulposus fibrosis in rats with intervertebral disc degeneration. Int J Mol Med 2021; 48.
43. Che Z, Xueqin J, Zhang Z. LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p. Bioengineered 2021; 12: 11201-12.
44. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 2004; 204: 47-54.
45. Bachmeier BE, Nerlich A, Mittermaier N, et al. Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur Spine J 2009; 18: 1573-86.
46. Zhao K, Chen M, Liu T, et al. Rhizoma drynariae total flavonoids inhibit the inflammatory response and matrix degeneration via MAPK pathway in a rat degenerative cervical intervertebral disc model. Biomed Pharmacother 2021; 138: 111466.
47. Wei F, Zhong R, Zhou Z, et al. In vivo experimental intervertebral disc degeneration induced by bleomycin in the rhesus monkey. BMC Musculoskelet Disord 2014; 15: 340.
48. Zhao CQ, Jiang LS, Dai LY. Programmed cell death in intervertebral disc degeneration. Apoptosis 2006; 11: 2079-88.
49. Li D, Zhu B, Ding L, Lu W, Xu G, Wu J. Role of the mitochondrial pathway in serum deprivation-induced apoptosis of rat endplate cells. Biochem Biophys Res Commun 2014; 452: 354-60.
50. Tu J, Li W, Zhang Y, et al. Simvastatin inhibits IL-1β-induced apoptosis and extracellular matrix degradation by suppressing the NF-kB and MAPK pathways in nucleus pulposus cells. Inflammation 2017; 40: 725-34.
51. Gruber HE, Hoelscher GL, Ingram JA, Bethea S, Zinchenko N, Hanley EJ. Variations in aggrecan localization and gene expression patterns characterize increasing stages of human intervertebral disk degeneration. Exp Mol Pathol 2011; 91: 534-9.
52. Peng B, Hao J, Hou S, et al. Possible pathogenesis of painful intervertebral disc degeneration. Spine (Phila Pa 1976) 2006; 31: 560-6.
53. Bian Q, Jain A, Xu X, et al. Excessive activation of TGFβ by spinal instability causes vertebral endplate sclerosis. Sci Rep 2016; 6: 27093.
54. Qin Z, Xia W, Fisher GJ, Voorhees JJ, Quan T. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts. Cell Commun Signal 2018; 16: 18.
55. Heldin CH, Moustakas A. Role of Smads in TGFβ signaling. Cell Tissue Res 2012; 347: 21-36.
56. Moustakas A, Heldin CH. The regulation of TGFbeta signal transduction. Development 2009; 136: 3699-714.
57. He W, Li AG, Wang D, et al. Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. Embo J 2002; 21: 2580-90.
58. Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact 2018; 292: 76-83.
59. Chen SJ, Ning H, Ishida W, et al. The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression. J Biol Chem 2006; 281: 21183-97.
60. Ghosh AK, Yuan W, Mori Y, Varga J. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000; 19: 3546-55.
61. Yang H, Yuan C, Wu C, et al. The role of TGF-β1/Smad2/3 pathway in platelet-rich plasma in retarding intervertebral disc degeneration. J Cell Mol Med 2016; 20: 1542-9.
Outlines

/